Biotribological properties of nano zirconium dioxide and hydroxyapatite-reinforced polyetheretherketone (HA/ZrO2/PEEK) biocomposites

Role of Ti3AlC2 MAX phase in regulating biodegradation and improving electrical properties of calcium silicate ceramic for bone repair applications

Calcium silicate ceramic is a promising bioceramic for various biomedical applications, but its high biodegradation rate and low strength restrict its clinical utility. As a result, the study devised an innovative solution to address these issues by utilizing the titanium aluminum carbide phase, potentially for the first time in biological applications, in conjugation with hydroxyapatite. Then, using powder metallurgy technology, they added these phases to calcium silicate to create nanocomposites. After soaking in simulated body fluid for ten days, the produced nanocomposites were assessed for bioactivity and biodegradability using scanning electron microscopy, inductively coupled plasma-atomic emission spectroscopy, and weight loss assays. Their electrical and dielectric properties were also measured before and after soaking in the simulated body fluid solution. Furthermore, the tribo-mechanical properties of all sintered samples were measured. Interestingly, adding 40% hydroxyapatite nanoparticles to calcium silicate reduced the porosity from 12 to 6%. However, adding five vol% of the titanium aluminum carbide phase to the same sample increased the porosity to 8%. Importantly, these recorded percentages of porosity were comparable to those of compact bone porosity, which range from 5 to 13%. The addition of hydroxyapatite and titanium aluminum carbide phase significantly improved the rapid biodegradation of calcium silicate, albeit with a slight decrease in its bioactive properties, as evidenced by the incomplete surface coverage of the samples with the hydroxyapatite layer in the scanning electron microscopy images. The electrical properties of the nanocomposites were better with the addition of hydroxyapatite and titanium aluminum carbide phase, which helped the bone heal faster. The addition of a titanium aluminum carbide phase significantly improved the mechanical properties of the resulting nanocomposites. For example, the calculated values for compressive strength of all examined samples were 131, 115, 105, 147, and 135 MPa. Based on the results, the prepared samples can be used in orthopaedic and dental applications.

Anticancer and bone-enhanced nano-hydroxyapatite/gelatin/polylactic acid fibrous membrane with dual drug delivery and sequential release for osteosarcoma

Surgical resection of osteosarcoma is always accompanied by residual metastasis of tumor cells and bone tissue defects. In this work, a novel kind of gelatin/polylactic acid (PLA) coaxial fiber membrane with a shell layer containing doxorubicin-loaded hydroxyapatite (DOX@nHAp) nanoparticles and a core layer containing Icariin (ICA) was developed for antitumor and bone enhancement at the defect site. Physical evaluation displayed that the composite membrane provided moderate hydrophilicity, enhanced tensile strength (Dry: 2-3 MPa, wet: 1-2 MPa) and elasticity (70-100 %), as well as increased specific surface area and pore volume (19.39 m²/g and 0.16 cm³/g). In SBF, DOX@nHAp in the fibers promoted biomineralization on the fiber surface. In in vitro evaluation, approximately 80 % of DOX had a short-term release during the first 8 days, followed by long-term release behavior of ICA for up to 40 days. CCK-8 results confirmed that the membrane could actively support MC3T3-E1 cells proliferation and was conductive to high alkaline phosphatase expression, while the viability of MG-63 cells was effectively inhibited to 50 %. Thus, the dual-loaded fibrous membrane with a coaxial structure and nHAp is a promising system for anticancer and defects reconstruction after osteosarcoma surgery.